Get started
Author

Peeter Padrik

Preliminary safety and efficacy of first-line pertuzumab combined with trastuzumab and taxane therapy for HER2-positive locally recurrent or metastatic breast cancer (PERUSE)
2019 · T. Bachelot, E. Ciruelos, et al. · Annals of Oncology · 116
PDF
Final results from the PERUSE study of first-line pertuzumab plus trastuzumab plus a taxane for HER2-positive locally recurrent or metastatic breast cancer, with a multivariable approach to guide prognostication
2021 · D. Miles, E. Ciruelos, et al. · Annals of Oncology · 98
PDF
Phase I Clinical Trial of Marizomib (NPI-0052) in Patients with Advanced Malignancies Including Multiple Myeloma: Study NPI-0052-102 Final Results
2016 · Simon J. Harrison, Paul Mainwaring, et al. · Clinical Cancer Research · 76
Polygenic prediction of breast cancer: comparison of genetic predictors and implications for risk stratification
2019 · Kristi Läll, Maarja Lepamets, et al. · BMC Cancer · 46
Identifying women at risk for delayed presentation of breast cancer: a cross-sectional study in Estonia
2013 · Kaire Innos, Peeter Padrik, et al. · BMC Public Health · 41
PDF
Genotype-first approach to the detection of hereditary breast and ovarian cancer risk, and effects of risk disclosure to biobank participants
2020 · Liis Leitsalu, Marili Palover, et al. · European Journal of Human Genetics · 38
PDF
Sex differences in cancer survival in Estonia: a population-based study
2015 · Kaire Innos, Peeter Padrik, et al. · BMC Cancer · 37
PDF
A case report and follow-up of the first live birth after heterotopic transplantation of cryopreserved ovarian tissue in Eastern Europe
2019 · Triin Tammiste, Keiu Kask, et al. · BMC Women s Health · 28
PDF
Trends in incidence and survival of cutaneous malignant melanoma in Estonia: a population-based study
2016 · Peeter Padrik, Ann Valter, et al. · Acta Oncologica · 26
PDF
Optimizing treatment for patients with metastatic renal cell carcinoma in the central and Eastern European region
2011 · Eduard Vrdoljak, Tudor Ciuleanu, et al. · Expert Opinion on Pharmacotherapy · 23
Time-gated luminescence assay using nonmetal probes for determination of protein kinase activity-based disease markers
2012 · Marje Kasari, Peeter Padrik, et al. · Analytical Biochemistry · 21
A randomized phase II trial of irinotecan in combination with infusional or two different bolus 5-fluorouracil and folinic acid regimens as first-line therapy for advanced colorectal cancer
2003 · K. Bouzid, S. Khalfallah, et al. · Annals of Oncology · 21
PDF
Time trends in population-based breast cancer survival in Estonia: Analysis by age and stage
2013 · Aleksei Baburin, Tiiu Aareleid, et al. · Acta Oncologica · 20
PDF
Guidance for the Clinical Use of the Breast Cancer Polygenic Risk Scores
2025 · Peeter Padrik, Neeme Tõnisson, et al. · Cancers · 19
Increasing kidney cancer incidence and survival in Estonia: role of age and stage
2018 · Kaire Innos, Teesi Sepp, et al. · Acta Oncologica · 19
PDF
BRCA1 mutations in women with familial or early-onset breast cancer and BRCA2 mutations in familial cancer in Estonia
2010 · Kristiina Tamboom, Krista Kaasik, et al. · Hereditary Cancer in Clinical Practice · 18
PDF
Implementation of Risk-Stratified Breast Cancer Prevention With a Polygenic Risk Score Test in Clinical Practice
2023 · Peeter Padrik, Mikk Puustusmaa, et al. · Breast Cancer Basic and Clinical Research · 15
Precise, Genotype-First Breast Cancer Prevention: Experience With Transferring Monogenic Findings From a Population Biobank to the Clinical Setting
2022 · Hannes Jürgens, Laura Roht, et al. · Frontiers in Genetics · 14
PDF
Renal cell carcinoma: changes in natural history and treatment of metastatic disease
2007 · Peeter Padrik · DSpace repository (University of Tartu) · 14
PDF
Clinical trial of NPI-0052 in advanced malignancies including lymphoma and leukemia (advanced malignancies arm)
2009 · A. R. Townsend, M. Millward, et al. · Journal of Clinical Oncology · 11
Combination therapy with capecitabine and interferon alfa-2A in patients with advanced renal cell carcinoma: A phase II study
2004 · Peeter Padrik, Krista Leppik, et al. · Urologic Oncology Seminars and Original Investigations · 10
A Breast Cancer Polygenic Risk Score Is Feasible for Risk Stratification in the Norwegian Population
2023 · Bayram Cevdet Akdeniz, Morten Mattingsdal, et al. · Cancers · 9
PDF
Prognostic Factors of Immunotherapy in Metastatic Renal Cell Carcinoma
2003 · Peeter Padrik · Medical Oncology · 8
Current standards in the treatment of metastatic breast cancer with focus on Lapatinib: a review by a Central European Consensus Panel
2010 · Guenther G. Steger, Jitka Abrahámová, et al. · Wiener klinische Wochenschrift · 7
Phase 1 Clinical Trial of the Novel Structure Proteasome Inhibitor NPI-0052.
2009 · Andrew Spencer, Michael Millward, et al. · Blood · 7
Works count: 62
Citation count: 795
H-index: 16
I10-index: 21
Year
Topic
Type